Abbott Laboratories (ABT)

Abbott Laboratories Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	-	7,616	6,896	9,882	9,799	6,838
Short-Term Investments	-	351	383	288	450	310
Trading Asset Securities	-	1	-	-	-	-
Cash & Short-Term Investments	7,282	7,968	7,279	10,170	10,249	7,148
Cash Growth	-6.50%	9.47%	-28.43%	-0.77%	43.38%	72.66%
Receivables	-	6,925	6,565	6,218	6,487	6,414
Inventory	-	6,194	6,570	6,173	5,157	5,012
Prepaid Expenses	-	2,179	2,087	2,251	2,054	1,777
Other Current Assets	-	390	169	412	292	90
Total Current Assets	-	23,656	22,670	25,224	24,239	20,441
Property, Plant & Equipment	-	11,733	11,276	10,278	10,112	10,130
Long-Term Investments	-	573	485	468	512	665
Goodwill	-	23,108	23,679	22,799	23,231	23,744
Other Intangible Assets	-	6,647	8,815	10,454	12,739	14,784
Long-Term Deferred Tax Assets	-	15,384	5,975	-	-	2,418
Other Long-Term Assets	-	313	314	5,215	4,363	366
Total Assets	-	81,414	73,214	74,438	75,196	72,548
Accounts Payable	-	4,195	4,295	4,607	4,408	3,946
Accrued Expenses	-	6,459	6,543	6,925	6,464	5,842
Short-Term Debt	-	-	-	-	-	213
Current Portion of Long-Term Debt	-	1,500	1,080	2,271	754	7
Current Portion of Leases	-	254	245	230	245	241
Current Income Taxes Payable	-	594	492	343	306	362
Other Current Liabilities	-	1,155	1,186	1,113	928	1,296
Total Current Liabilities	-	14,157	13,841	15,489	13,105	11,907
Long-Term Debt	-	12,676	13,694	14,522	17,296	18,527
Long-Term Leases	-	896	949	943	956	902
Pension & Post-Retirement Benefits	-	1,880	1,964	1,784	2,738	3,119
Long-Term Deferred Tax Liabilities	-	512	568	991	1,392	1,406
Other Long-Term Liabilities	-	3,392	3,371	3,804	3,685	3,684
Total Liabilities	-	33,513	34,387	37,533	39,172	39,545
Common Stock	-	25,153	24,869	24,709	24,470	24,145
Retained Earnings	-	47,261	37,554	35,257	31,528	27,627
Treasury Stock	-	-16,844	-15,981	-15,229	-11,822	-10,042
Comprehensive Income & Other	-	-7,906	-7,839	-8,051	-8,374	-8,946
Total Common Equity	50,565	47,664	38,603	36,686	35,802	32,784
Minority Interest	-	237	224	219	222	219
Shareholders' Equity	50,829	47,901	38,827	36,905	36,024	33,003
Total Liabilities & Equity	-	81,414	73,214	74,438	75,196	72,548
Total Debt	13,470	15,326	15,968	17,966	19,251	19,890
Net Cash (Debt)	-6,188	-7,358	-8,689	-7,796	-9,002	-12,742
Net Cash Per Share	-3.54	-4.21	-4.97	-4.42	-5.03	-7.13
Filing Date Shares Outstanding	1,749	1,734	1,735	1,738	1,763	1,772
Total Common Shares Outstanding	1,749	1,732	1,734	1,738	1,764	1,771
Working Capital	-	9,499	8,829	9,735	11,134	8,534
Book Value Per Share	29.05	27.52	22.26	21.11	20.29	18.51
Tangible Book Value	20,693	17,909	6,109	3,433	-168	-5,744
Tangible Book Value Per Share	11.89	10.34	3.52	1.98	-0.10	-3.24
Land	-	528	529	511	525	538
Buildings	-	4,207	4,161	4,053	4,007	4,014
Machinery	-	15,517	15,179	14,164	13,528	12,884
Construction In Progress	-	2,488	2,064	1,484	1,304	1,357

Updated Oct 15, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q